• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载甲氨蝶呤壳聚糖纳米载体的粒径优化 2 因子全面实验模型:实验设计(DoE)方法。

2 Full Factorial Model for Particle Size Optimization of Methotrexate Loaded Chitosan Nanocarriers: A Design of Experiments (DoE) Approach.

机构信息

Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science & Technology, India.

出版信息

Biomed Res Int. 2018 Sep 25;2018:7834159. doi: 10.1155/2018/7834159. eCollection 2018.

DOI:10.1155/2018/7834159
PMID:30356374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6176313/
Abstract

PURPOSE

To build and inquire a statistically significant mathematical model for manufacturing methotrexate loaded chitosan nanoparticles (CsNP) of desired particle size. The study was also performed to evaluate the effect of formulation variables in the explored design space.

METHOD

Ionotropic gelation technique was followed for chitosan nanocarriers by changing formulation variables suggested as per Design Expert software. Altering the levels of Chitosan, tripolyphosphate, methotrexate by 2 factorial design served the purpose. The CsNP were characterized for nanocarrier formation, particle size, and statistical analysis. Then mathematical model was statistically analyzed for fabricating desired formulation having particle size less than 200nm.

RESULTS

FT-IR, XRD reports confirmed the structural change in chitosan which lead to the formation of CsNP. For particle size, linear model was found to be best fit to explain effect of variables. Besides, high R (0.9958) defends the constancy of constructed model. Chitosan exhibited higher t-value in Pareto chart and a p-value <0.0001. Based on maximum desirability, optimization was performed and amount of variables for preparing CsNP of 180nm was predicted. The experiment was carried out with software suggested combination and particle size was found to be 176±4nm.

CONCLUSION

Low p-value endorsed the greater dominance of chitosan on particle size. Good model adequacy and small percentage error between predicted and experimented value established the reliability of constructed model for robust preparation of CsNP.

摘要

目的

建立并研究一个具有统计学意义的数学模型,用于制备具有所需粒径的甲氨蝶呤负载壳聚糖纳米粒子(CsNP)。本研究还评估了制剂变量在探索设计空间中的影响。

方法

采用离子凝胶化技术,通过改变设计专家软件建议的制剂变量来制备壳聚糖纳米载体。通过 2 因子设计改变壳聚糖、三聚磷酸钠、甲氨蝶呤的水平来达到目的。对 CsNP 进行纳米载体形成、粒径和统计分析。然后对数学模型进行统计分析,以制备粒径小于 200nm 的理想制剂。

结果

FT-IR、XRD 报告证实了壳聚糖结构的变化,导致了 CsNP 的形成。对于粒径,线性模型被发现是最适合解释变量影响的模型。此外,高 R(0.9958)证明了所构建模型的稳定性。壳聚糖在 Pareto 图中表现出较高的 t 值和 p 值<0.0001。基于最大理想度进行了优化,并预测了制备粒径为 180nm 的 CsNP 的变量用量。实验采用软件建议的组合进行,发现粒径为 176±4nm。

结论

低 p 值证明了壳聚糖对粒径的更大主导性。良好的模型充分性和预测值与实验值之间的小百分比误差确立了所构建模型用于稳健制备 CsNP 的可靠性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/27798ad658b9/BMRI2018-7834159.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/80ee0cd436ed/BMRI2018-7834159.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/a537f0201ee8/BMRI2018-7834159.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/d1bf8bd48f55/BMRI2018-7834159.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/cddad95dcbdd/BMRI2018-7834159.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/2c9245a4f357/BMRI2018-7834159.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/27798ad658b9/BMRI2018-7834159.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/80ee0cd436ed/BMRI2018-7834159.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/a537f0201ee8/BMRI2018-7834159.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/d1bf8bd48f55/BMRI2018-7834159.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/cddad95dcbdd/BMRI2018-7834159.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/2c9245a4f357/BMRI2018-7834159.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcac/6176313/27798ad658b9/BMRI2018-7834159.006.jpg

相似文献

1
2 Full Factorial Model for Particle Size Optimization of Methotrexate Loaded Chitosan Nanocarriers: A Design of Experiments (DoE) Approach.载甲氨蝶呤壳聚糖纳米载体的粒径优化 2 因子全面实验模型:实验设计(DoE)方法。
Biomed Res Int. 2018 Sep 25;2018:7834159. doi: 10.1155/2018/7834159. eCollection 2018.
2
Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.采用Box-Behnken设计法制备、表征及优化叶酸-壳聚糖-甲氨蝶呤核壳纳米粒用于肿瘤靶向给药
AAPS PharmSciTech. 2017 Jan 1;18(1):115-129. doi: 10.1208/s12249-015-0445-3. Epub 2016 Feb 19.
3
Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization.在新型pH值下甲氨蝶呤负载于壳聚糖纳米颗粒中:响应面建模、优化与表征
Int J Biol Macromol. 2016 Oct;91:630-9. doi: 10.1016/j.ijbiomac.2016.06.014. Epub 2016 Jun 6.
4
Factorial Screening and Optimization of Chitosan Based Gel for Urapidil Loaded Microparticle using Reduced Factorial Design.基于缩减因子设计的乌洛地平载药微球用壳聚糖凝胶的析因筛选和优化。
Comb Chem High Throughput Screen. 2020;23(10):1049-1063. doi: 10.2174/1386207323666200628110552.
5
Optimization of production parameters for fabrication of thymol-loaded chitosan nanoparticles.优化载有百里香酚的壳聚糖纳米粒子制备的生产参数。
Int J Biol Macromol. 2020 May 15;151:230-238. doi: 10.1016/j.ijbiomac.2020.02.096. Epub 2020 Feb 11.
6
Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.离子凝胶法制备壳聚糖纳米颗粒:最新进展综述
Crit Rev Ther Drug Carrier Syst. 2016;33(2):107-58. doi: 10.1615/CritRevTherDrugCarrierSyst.2016014850.
7
Design and Development of Lomustine Loaded Chitosan Nanoparticles for Efficient Brain Targeting.洛莫司汀载壳聚糖纳米粒的设计与研制及其高效脑靶向性
Cardiovasc Hematol Agents Med Chem. 2020;18(1):45-54. doi: 10.2174/1871525718666200203112502.
8
"Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".Box-Behnken设计在富马酸喹硫平壳聚糖纳米粒优化及开发中的应用——用于经鼻途径脑递送*
Int J Biol Macromol. 2016 Aug;89:206-18. doi: 10.1016/j.ijbiomac.2016.04.076. Epub 2016 Apr 27.
9
Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.采用两水平析因设计方法优化制备寡霉素载叶酸偶联壳聚糖纳米粒作为肿瘤靶向给药系统的工艺。
Int J Nanomedicine. 2011;6:3429-41. doi: 10.2147/IJN.S27157. Epub 2011 Dec 20.
10
Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.离子凝胶法制备吉非替尼负载聚合物纳米粒及其表征
Pharm Nanotechnol. 2017;5(4):301-309. doi: 10.2174/2211738505666171004124109.

引用本文的文献

1
Implementation of green-assessed nanotechnology and quality by design approach for development of optical sensor for determination of tobramycin in ophthalmic formulations and spiked human plasma.通过绿色评估纳米技术和质量源于设计方法开发用于测定眼科制剂和加标人血浆中妥布霉素的光学传感器。
BMC Chem. 2024 Jul 15;18(1):131. doi: 10.1186/s13065-024-01234-y.
2
Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance.探索盐酸法舒地尔的眼部吸收途径以开发性能更优的纳米颗粒制剂。
Pharmaceutics. 2024 Jan 15;16(1):112. doi: 10.3390/pharmaceutics16010112.
3

本文引用的文献

1
Design of experiments (DoE) in pharmaceutical development.药物研发中的实验设计
Drug Dev Ind Pharm. 2017 Jun;43(6):889-901. doi: 10.1080/03639045.2017.1291672. Epub 2017 Feb 23.
2
Experiences of patients undergoing chemotherapy - a qualitative study of adults attending Uganda Cancer Institute.接受化疗患者的经历——对乌干达癌症研究所成年就诊者的定性研究
Afr Health Sci. 2016 Sep;16(3):744-749. doi: 10.4314/ahs.v16i3.14.
3
Biological preparation of chitosan nanoparticles and its in vitro antifungal efficacy against some phytopathogenic fungi.
Research Progress of Polysaccharide-Gold Nanocomplexes in Drug Delivery.
多糖-金纳米复合物在药物递送中的研究进展
Pharmaceutics. 2024 Jan 9;16(1):88. doi: 10.3390/pharmaceutics16010088.
4
Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box-Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route.采用Box-Behnken设计法定制载利培酮的糖质体原位凝胶,经鼻内途径治疗精神分裂症诱导大鼠。
Pharmaceutics. 2023 Oct 24;15(11):2521. doi: 10.3390/pharmaceutics15112521.
5
Impact of nanocarrier aggregation on EPR-mediated tumor targeting.纳米载体聚集对增强渗透与滞留效应介导的肿瘤靶向的影响。
Front Bioeng Biotechnol. 2023 Jul 21;11:1222693. doi: 10.3389/fbioe.2023.1222693. eCollection 2023.
6
Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management.设计开发和优化多功能阿霉素负载吲哚菁绿前体囊泡衍生的非离子囊泡用于肿瘤管理。
Sci Rep. 2023 Jan 30;13(1):1697. doi: 10.1038/s41598-023-28891-8.
7
Optimization of Formulation Parameters in Preparation of Dropping Pills by Solid Dispersion Using 2 Full Experimental Design.采用二水平全因子试验设计优化固体分散体滴丸制剂参数的研究
Pharmaceuticals (Basel). 2022 Nov 19;15(11):1433. doi: 10.3390/ph15111433.
8
Design and Preparation of a Biobased Colorimetric pH Indicator from Cellulose and Pigments of Bacterial Origin, for Potential Application as Smart Food Packaging.基于纤维素和细菌源色素设计并制备一种生物基比色pH指示剂,用于智能食品包装的潜在应用。
Polymers (Basel). 2022 Sep 15;14(18):3869. doi: 10.3390/polym14183869.
9
Investigation of Alogliptin-Loaded In Situ Gel Implants by 2 Factorial Design with Glycemic Assessment in Rats.通过二因素设计对大鼠进行血糖评估来研究载有阿格列汀的原位凝胶植入物。
Pharmaceutics. 2022 Sep 5;14(9):1867. doi: 10.3390/pharmaceutics14091867.
10
Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment.功能化壳聚糖纳米粒经皮传递皮肤美白剂:一种临床增强治疗黄褐斑疗效的方法。
Drug Deliv. 2022 Dec;29(1):1212-1231. doi: 10.1080/10717544.2022.2058652.
壳聚糖纳米粒子的生物制备及其对几种植物病原真菌的体外抑菌活性。
Carbohydr Polym. 2016 Oct 20;151:321-325. doi: 10.1016/j.carbpol.2016.05.033. Epub 2016 May 13.
4
Design of Nanoparticle-Based Carriers for Targeted Drug Delivery.用于靶向给药的纳米颗粒载体设计
J Nanomater. 2016;2016. doi: 10.1155/2016/1087250.
5
Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia.甲氨蝶呤耐药与儿童急性淋巴细胞白血病治疗结果的关系
J Hematol Oncol. 2015 May 29;8:61. doi: 10.1186/s13045-015-0158-9.
6
Response surface optimization of ultrasound assisted extraction of pectin from pomegranate peel.超声辅助提取石榴皮中果胶的响应面优化
Int J Biol Macromol. 2015 Jan;72:1323-8. doi: 10.1016/j.ijbiomac.2014.10.037. Epub 2014 Oct 27.
7
Ultrasound-assisted extraction of pectin from sisal waste.超声辅助提取剑麻废料中的果胶。
Carbohydr Polym. 2015 Jan 22;115:732-8. doi: 10.1016/j.carbpol.2014.07.058. Epub 2014 Aug 4.
8
A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.基于质量源于设计的研究:考察原料药性质、工艺方法和辅料变异性对药物产品质量属性的相对影响。
J Pharm Sci. 2014 Feb;103(2):527-38. doi: 10.1002/jps.23810. Epub 2013 Dec 20.
9
Acidic extracellular microenvironment and cancer.酸性细胞外微环境与癌症。
Cancer Cell Int. 2013 Sep 3;13(1):89. doi: 10.1186/1475-2867-13-89.
10
pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.壳聚糖纳米粒子的 pH 响应性药物递送作为他莫昔芬载体,用于乳腺癌细胞的有效抗肿瘤活性。
Colloids Surf B Biointerfaces. 2013 Nov 1;111:117-23. doi: 10.1016/j.colsurfb.2013.05.018. Epub 2013 May 22.